Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2024-11-07 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
113年第3季海外子公司投資
Interim / Quarterly Report Classification · 90% confidence The document contains financial data related to investment in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period. It references the 3rd quarter of the 113th fiscal year, indicating a quarterly or interim reporting period. The content includes substantive financial data and analysis rather than just an announcement or certification. The document length is short but contains actual financial figures, so it is not merely a report publication announcement or regulatory filing. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-11-07 Chinese
113年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory limits, referencing approvals by the Ministry of Economic Affairs Investment Commission. The document is relatively short (1289 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or announcement. It does not contain comprehensive financial statements or management discussion, nor is it an announcement of a report publication. This type of document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-11-07 Chinese
公告本公司國內第二次無擔保轉換公司債113年第3季轉換 普通股之發行新股基準日
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement from a listed company (1786 科妍) regarding the issuance of new shares due to the conversion of domestic unsecured convertible bonds. It includes details such as the board resolution date, amount and number of shares issued, share par value, and capital increase before and after issuance. The content focuses on capital changes related to share issuance rather than a full financial report or earnings release. The document length is short (958 characters) and it is a specific announcement about share issuance. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2024-11-07 Chinese
公告本公司董事會通過113年第3季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1786 科妍) reporting the board's approval of the consolidated financial report for the third quarter of the year 113 (Taiwan calendar, equivalent to 2024). It includes cumulative financial data from January 1 to September 30, such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity. The document is short (901 characters) and primarily serves as a notification of the board's approval of the quarterly financial report rather than the full detailed report itself. This fits the definition of an Interim / Quarterly Report (IR) because it contains substantive financial data for a period shorter than a full fiscal year. It is not merely an announcement of report publication (RPA) or a regulatory filing (RNS) since it includes actual financial figures. Therefore, the correct classification is IR with high confidence. 9M 2024
2024-11-07 Chinese
113年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (科妍) providing information about fund loans and endorsement guarantees, all showing zero balances. It is very short (601 characters) and contains tabular data about financial guarantees and loans but no detailed financial statements or analysis. There is no indication of it being a full report like an Annual Report (10-K) or Interim Report (IR). It is more of a regulatory disclosure or compliance update. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-11-07 Chinese
113年10月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief summary report of monthly and cumulative revenue figures for a company named 科妍, presented in a tabular format with percentage changes and notes on accounting standards (IFRS). It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is very short (767 characters), and it primarily provides key financial facts and figures. This matches the description of a Fund Information / Factsheet (FS), which is a brief summary of key company facts and financials. It is not an announcement of a report, nor a full report itself, but a concise financial summary.
2024-11-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.